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Abstract
Background: Recent advance in genetic studies added the confirmed susceptible loci for type 2 diabetes to eighteen. In this
study, we attempt to analyze the independent and joint effect of variants from these loci on type 2 diabetes and clinical
phenotypes related to glucose metabolism.
Methods/Principal Findings: Twenty-one single nucleotide polymorphisms (SNPs) from fourteen loci were successfully
genotyped in 1,849 subjects with type 2 diabetes and 1,785 subjects with normal glucose regulation. We analyzed the allele
and genotype distribution between the cases and controls of these SNPs as well as the joint effects of the susceptible loci
on type 2 diabetes risk. The associations between SNPs and type 2 diabetes were examined by logistic regression. The
associations between SNPs and quantitative traits were examined by linear regression. The discriminative accuracy of the
prediction models was assessed by area under the receiver operating characteristic curves. We confirmed the effects of SNPs
from PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 on risk for type 2 diabetes, with odds
ratios ranging from 1.114 to 1.406 (P value range from 0.0335 to 1.37E-12). But no significant association was detected
between SNPs from WFS1, FTO, JAZF1, TSPAN8-LGR5, THADA, ADAMTS9, NOTCH2-ADAM30 and type 2 diabetes. Analyses on
the quantitative traits in the control subjects showed that THADA SNP rs7578597 was association with 2-h insulin during oral
glucose tolerance tests (P=0.0005, empirical P=0.0090). The joint effect analysis of SNPs from eleven loci showed the
individual carrying more risk alleles had a significantly higher risk for type 2 diabetes. And the type 2 diabetes patients with
more risk allele tended to have earlier diagnostic ages (P=0.0006).
Conclusions/Significance: The current study confirmed the association between PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B,
IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 and type 2 diabetes. These type 2 diabetes risk loci contributed to the disease
additively.
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Introduction
Type 2 diabetes is a complex disease characterized by elevated
blood glucose, caused mainly by impairment in both insulin action
and beta cell function. Although the sharp increase in prevalence
of type 2 diabetes worldwide is attributed to changes in individual
environmental exposure pattern, genetic factors do predispose to
the disease [1]. Recently, spectacular advance was made in
identifying susceptible genes involved in type 2 diabetes through
genome-wide association studies (GWAS). Several groups reported
independent GWAS in Caucasians, which not only confirmed the
effect of PPARG, KCNJ11 and TCF7L2, but also identified six
novel susceptibility loci including CDKAL1, CDKN2A-CDKN2B,
IDE-KIF11-HHEX, IGF2BP2, SLC30A8 and FTO [2,3,4,5]. And
meta-analysis on three Caucasian GWAS yielded six additional
loci (JAZF1, TSPAN8-LGR5, THADA, ADAMTS9, NOTCH2-
ADAM30 and CDC123-CAMK1D) associated with type 2 diabetes
at genome-wide statistic significance [6]. Moreover, the first two
independent GWAS in East Asian population added KCNQ1 to the
list of type 2 diabetes susceptible gene [7,8]. In addition with two
well replicated candidate genes TCF2 and WFS1 [9,10], eighteen
susceptible loci of type 2 diabetes were well recognized to date.
Several researches tried to replicate some of these loci in the
Asian populations and confirmed the effects of genetic variants in
CDKAL1, CDKN2A-CDKN2B, IDE-KIF-HHEX, IGF2BP2,
SLC30A8, FTO and TCF7L2 [11,12,13]. However, limited study
analyzed all these susceptible loci in the Asian population.
Previously, we reported the association of TCF2 and KCNQ1
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7643genetic variants with type 2 diabetes in our case-control samples
[14,15], thus we tested the effects of genetic variants from the
other sixteen loci as well as the joint effect of variants from all these
eighteen loci on type 2 diabetes and related clinical traits in this
study.
Methods
Ethnic statement
This study was approved by the institutional review board of
Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
was in accordance with the principle of the Helsinki Declaration
II. Written informed consent was obtained from each participant.
Study population
A total of 3,634 individuals, comprising 1,849 type 2 diabetes
patients and 1,785 normal controls, were included in the present
study. The type 2 diabetes patients were recruited from the
inpatient department of Shanghai Jiao Tong University Affiliated
Sixth People’s Hospital. Diabetes was defined according to 1999
World Health Organization criteria (fasting plasma glucose
$7.0 mmol/l and/or 2-h plasma glucose $11.1 mmol/l) [16].
Individuals with glutamic acid decarboxylase and/or protein
tyrosine phosphatase IA-2 antibodies positive were excluded and
mitochondria tRNA
Leu(UUR) nt3243 A-to-G mutation carriers
were excluded as well. The controls were selected from the
participants of Shanghai Diabetes Study [17]. In the present study,
the inclusion criteria for the control subjects were: 1) over 40 years
old; 2) with normal glucose regulation confirmed by a standard
75 g oral glucose tolerance test (OGTT); 3) with negative family
history of diabetes by a standard questionnaire. For each
participant, glucose tolerance status was confirmed according to
1999 World Health Organization criteria (fasting plasma glucose
,6.1 mmol/l and 2-h postprandial plasma glucose ,7.8 mmol/l).
The clinical characteristics of the study groups were shown in
Table 1.
At the level of significance of 0.05, our case-control samples had
over 80% power to detect a minimum odds ratio (OR) of 1.15 for
a single nucleotide polymorphism (SNP) with minor allele
frequency (MAF) over 0.2, a minimum OR of 1.24 for a SNP
with MAF of 0.1 and a minimum OR of 1.33 for a SNP with MAF
of 0.05.
Biochemical and anthropometric measures
All participants underwent a detailed clinical investigation.
Anthropometric variables including height, weight, waist and hip
circumferences were measured. For the controls, blood samples
were obtained at 0 and 120 min during standard 75 g OGTTs.
Plasma glucose concentrations were measured by the glucose
oxidase-peroxidase method using commercial kits (Shanghai
Biological Products Institution, Shanghai, China). Serum insulin
levels were measured by radioimmunoassay (Linco Research, St
Charles, MO, USA). Homeostasis model assessment (HOMA) was
used to estimate insulin resistance (HOMA-IR) and b-cell function
(HOMA-B) [18].
SNP selection and genotyping
We selected twenty-four SNPs from sixteen loci previously
reported to be associated with type 2 diabetes at a genome-wide
significance level, including PPARG (rs1801282), KCNJ11 (rs5219),
WFS1 (rs10010131), TCF7L2 (rs7903146), CDKAL1 (rs10946398,
rs7754840, rs9460546, rs7756992 and rs9465871), CDKN2A-
CDKN2B (rs564398 and rs10811161), IDE-KIF11-HHEX
(rs10509645, rs1111875 and rs10748582), IGF2BP2 (rs7651090),
SLC30A8 (rs13266634), FTO (rs8050136), JAZF1 (rs864754),
TSPAN8-LGR5 (rs7961581), THADA (rs7578597), ADAMTS9
(rs4607103), NOTCH2-ADAM30 (rs2641348 and rs10923931)
and CDC123-CAMK1D (rs12779790). All the SNPs were geno-
typed using MassARRAY iPLEX system (MassARRAY Compact
Analyzer, Sequenom, San Diego, CA). The genotyping underwent
several quality control procedures. Two SNPs (rs12779790 and
rs7903146) were excluded because of low call rate (,90%). One
SNP (rs10923931) was excluded because of departure from Hardy-
Weinberg equilibrium (P,0.01). The overall call rate for the
remaining 21 SNPs was 96.8%. The concordant rate calculated
based on 100 duplicates for each SNP was 99.6%.
Statistical analyses
Allele frequencies between cases and controls were compared
using x
2 test. The ORs with 95% confidence intervals (CIs) with
respect to the risk alleles were presented. Genotype distributions
between cases and controls were compared using logistic
regression under a log additive model in PLINK after adjusting
age, gender and BMI as confounding factors [19]. For genes with
multiple SNPs genotyped, independent SNP effects were deter-
mined by logistic regression. Correction of multiple testing on
allele association was performed using PLINK through 10,000
permutations that randomly permutated the case/control status
independent of genotypes.
For continuous trait analysis, quantitative trait association
analyses were performed by linear regression after adjusting age,
gender and BMI as confounding factors. Quantitative traits with
skewed distribution were transformed to approximate univariate
normality by natural logarithm. In order to adjust multiple
comparison, 1,000 permutations were performed for each trait to
assess empirical P values using PLINK [19]. Additive effect models
were used for SNPs with MAFs .0.05. For SNPs with MAFs
,0.05, dominant effect models were used because of the small
numbers of homozygotes of rare alleles.
The receiver operating characteristic (ROC) curves, a tool for
displaying the discriminatory ability of a diagnostic marker in
distinguishing between cases and controls, were used for
evaluation of discriminative accuracy of age, gender, BMI and
SNPs. The area under the ROC curve (AUC), the measurement of
the ability of a marker to discriminate between the cases and
controls, was calculated by using the logistic regression model.
AUC comparisons between ROC curves were performed by
MedCalc (version 10.3.2.0; Mariakerke, Belgium) using the
method of Hanley and McNeil for ROC curve analyses.
The statistic analyses were performed by using SAS for
Windows (version 8.0; SAS Institute, Cary, NC) unless specified
otherwise. As the genes analyzed in the current study were well
Table 1. Clinical characteristics of study population.
Type 2 diabetes
patients
Normal glucose
regulation subjects
Samples (n) 1,849 1,785
Male/Female (n) 970/879 736/1,049
Age (years) 61.21612.62 57.39612.37
Duration of diabetes (years) 6.0 (1.0, 10.0)
BMI (kg/m
2) 24.0463.51 23.5763.25
Data are shown as mean6SD or median (interquartile range).
doi:10.1371/journal.pone.0007643.t001
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considered as statistically significant.
Results
We first examined the potential effects of 21 SNPs successfully
genotyped on type 2 diabetes susceptibility in our Chinese case-
control samples. As shown in Table 2, the CDKN2A-CDKN2B
rs10811661 showed strong association to type 2 diabetes, with an
OR of 1.406 (95% CI 1.280–1.546) per risk allele T (P=1.37E-12).
In addition, SNPs from PPARG, KCNJ11, CDKAL1, IDE-KIF11-
HHEX, IGF2BP2 and SLC30A8 were also moderately associated
with type 2 diabetes, with ORs ranging from 1.114 to 1.282
(P,0.05). As multiple SNPs from CDKAL1 and IDE-KIF11-HHEX
were genotyped, we analyzed the linkage disequilibrium extent
amongtheSNPsfromthesameregion.ThefiveSNPsfromCDKAL1
and three SNPs from IDE-KIF11-HHEX were in linkage disequilib-
rium, respectively. We then used logistic regression to determine the
independent effects of these SNPs and found SNPs rs7756992 and
rs10748582 conferred independent risks for the disease in CDKAL1
and IDE-KIF11-HHEX regions respectively (data not shown).
However, after correction of multiple comparisons, only the
association between SNPs from CDKAL1, CDKN2A-CDKN2B, IDE-
KIF11-HHEX, IGF2BP2 and SLC30A8 and type 2 diabetes remained
to be significant. And we also found the WFS1 rs10010131 and FTO
rs8050136 showed trends towards association to type 2 diabetes in
our samples (0.05,P,0.1). However, we failed to replicate the
effects of CDKN2A-CDKN2B rs564398 and SNPs from JAZF1,
TSPAN8-LGR5, THADA, ADAMTS9, NOTCH2-ADAM30, which
were identified through meta-analysis of Caucasian GWAS.
We thenanalyzed the effectsof these SNPs onclinicalmeasurements
in the normal controls. As shown in Table 3, we found SLC30A8
rs13266634 was associated with fasting glucose (P=0.0118) and
TSPAN8-LGR5 rs7961581 was associated with 2-h glucose
(P=0.0404). For insulin levels, we found rs10811161, rs864754,
rs7961581 and rs7578597 were associated with 2-h insulin levels
(P=0.0005,0.0257). For BMI, no significant association was detected,
including FTO SNP rs8050136,which waspreviouslyreported to be an
obesity gene in the Caucasians. However, only the association between
THADA rs7578597 and 2-h insulin remained significant after
correction of multiple testing (empirical P=0.0090).
To further investigate if these susceptible loci affected the disease
additively, we examined joint effects of risk alleles of SNPs from
susceptible loci on type 2 diabetes. Here we analyzed if the individuals
carrying more risk allele tended to have a higher risk for the disease
and if the patients with more risk alleles tended to have an earlier
diagnostic age. We also analyzed the diagnostic value of these SNPs.
We only selected SNPs with P values less than 0.1. For loci with
multipleSNPsgenotyped,theSNPshowedstrongestassociationfrom
each locus was selected. Two additional SNPs, KCNQ1 rs2237892
and TCF2 rs4430796, which were previously genotyped and showed
significant association to type 2 diabetes in our samples, were also
Table 2. Association between SNPs from fourteen loci and type 2 diabetes in the Chinese.
Gene SNP
Chromo-
some
Chromosome
position
(Build 36)
Major/Minor
Allele
Risk
Allele
Risk allele
frequency OR (95%CI) Pallele Pgenotype
Empirical
P
Case Control
PPARG rs1801282 3 12368125 C:G C 0.950 0.939 1.246 (1.017–1.526) 0.0335 0.0701 0.4589
KCNJ11 rs5219 11 17366148 C:T T 0.425 0.394 1.138 (1.034–1.251) 0.0079 0.0031 0.1367
WFS1 rs10010131 4 6343816 G:A G 0.955 0.946 1.213 (0.975–1.510) 0.0824 0.0969 0.7816
CDKAL1 rs10946398 6 20769013 A:C C 0.441 0.414 1.114 (1.014–1.224) 0.0241 0.0074 0.3551
CDKAL1 rs7754840 6 20769229 G:C C 0.440 0.411 1.127 (1.027–1.238) 0.0119 0.0025 0.1967
CDKAL1 rs9460546 6 20771611 T:G G 0.444 0.411 1.145 (1.041–1.260) 0.0054 0.0014 0.0944
CDKAL1 rs7756992 6 20787688 G:A G 0.548 0.511 1.158 (1.056–1.272) 0.0020 0.0010 0.0364
CDKAL1 rs9465871 6 20825234 C:T C 0.554 0.522 1.140 (1.039–1.251) 0.0057 0.0021 0.1001
CDKN2A-CDKN2B rs564398 9 22019547 A:G G 0.120 0.118 1.020 (0.885–1.177) 0.7826 0.2922 1
CDKN2A-CDKN2B rs10811161 9 19269853 T:C T 0.604 0.520 1.406 (1.280–1.546) 1.37E-12 1.13E-13 0.0001
IDE-KIF11-HHEX rs10509645 10 94267846 A:C C 0.354 0.321 1.160 (1.052–1.280) 0.0031 0.0018 0.0561
IDE-KIF11-HHEX rs1111875 10 94452862 A:G G 0.310 0.273 1.201 (1.085–1.330) 0.0004 5.25E-05 0.0086
IDE-KIF11-HHEX rs10748582 10 94467199 A:T T 0.238 0.196 1.282 (1.146–1.435) 1.46E-5 1.51E-05 0.0005
IGF2BP2 rs7651090 3 186996086 A:G G 0.282 0.246 1.200 (1.079–1.334) 0.0008 0.0013 0.0141
SLC30A8 rs13266634 8 118253964 C:T C 0.613 0.559 1.251 (1.138–1.374) 3.12E-6 1.60E-06 0.0002
FTO rs8050136 16 52373776 C:A A 0.130 0.118 1.125 (0.978–1.294) 0.0996 0.1456 0.8414
JAZF1 rs864754 7 25918763 T:A T 0.759 0.751 1.046 (0.934–1.171) 0.4364 0.4359 0.9998
TSPAN8-LGR5 rs7961581 12 69949369 T:C C 0.231 0.217 1.082 (0.965–1.212) 0.1779 0.4068 0.9710
THADA rs7578597 2 43586327 T:C T 0.994 0.994 1.013 (0.548–1.873) 0.9661 0.7604 1
ADAMTS9 rs4607103 3 64686944 C:T C 0.635 0.629 1.030 (0.934–1.137) 0.5510 0.8632 1
NOTCH2-ADAM30 rs2641348 1 120239407 T:C C 0.028 0.026 1.071 (0.801–1.433) 0.6443 0.9776 1
The OR with 95% CI shown is for the risk allele. Pallele is the P value for comparison of the allele distribution between the cases and controls. Pgenotype is the P value for
comparison of genotype distribution between the cases and controls after adjusting age, gender and BMI as confounding factors. Empirical P values were calculated
through 10,000 permutations for the difference of allele distribution between cases and controls.
doi:10.1371/journal.pone.0007643.t002
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rs1801282, KCNJ11 rs5219, WFS1 rs10010131, CDKAL1 rs7756992,
CDKN2A-CDKN2B rs10811161, IDE-KIF11-HHEX rs10748582,
IGF2BP2 rs7651090, SLC30A8 rs13266634, FTO rs8050136, KCNQ1
rs2237892 and TCF2 rs4430796) were selected into the analysis. And
we only included individuals with the genotypes of all these eleven
SNPs available (1,359 type 2 diabetes patients and 1,532 normogly-
caemic controls) into the analysis.
We found the proportion of type 2 diabetes patients increased in
the subgroups with more risk alleles (Fig. 1A) (Ptrend=1.34E-30).
When treating the individuals carrying less than 9 risk alleles (6.6%
of the study population) as reference group, the subgroups carrying
more risk alleles had a significantly higher risk for type 2 diabetes,
with each additional risk allele increased type 2 diabetes risk by
1.265-fold (95%CI: 1.214–1.318, P=2.66E-29). Moreover, we
found the number of risk alleles was significantly associated with
age-at-diagnosis in the type 2 diabetes patients. The patients
carrying more risk alleles tended to have a younger diagnostic age
(b=20.6060.17 years per each additional risk allele, P=0.0006)
(Fig. 1C). And this association remained significant after further
adjusting sex and BMI as confounding factors (b=–0.6560.18
years per risk allele, P=0.0002). We also evaluated the predictive
value of these genetic variants in the Chinese population. In our
samples, the AUC for clinical characteristic including age, sex and
BMI was 0.614 (95%CI 0.595–0.632) while the AUC for the
number of risk alleles was 0.621 (95%CI 0.604–0.639). But when
adding the number of risk alleles to the regression model of age,
sex and BMI, the AUC increased marginally to 0.668 (95%CI
0.650–0.685) (P=0.0002) (Fig. 1D). We also analyzed the joint
effect of SNPs from all sixteen loci (only excluding TCF7L2 and
CDC123-CAMK1D that failed genotyping) and got similar results
(data not shown).
Discussion
In this study, we confirmed the effects of variations in PPARG,
KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX,
IGF2BP2 and SLC30A8 on type 2 diabetes. The ORs of the risk
alleles were similar to those reported in Caucasians [2,3,4,5]. Our
finding also supported that WFS1 and FTO might participate in
the pathogenesis of type 2 diabetes, although the effects we
detected on rs10010131 and rs8050136 were not statistically
significant. The non-significance could be explained by the
different genetic background between Caucasian and Asian
populations. Compared with Caucasians, the MAFs of these two
variants were much rarer in the Chinese populations (0.05 vs. 0.40
for rs10010131 and 0.125 vs. 0.45 for rs8050136) [20,21], which
reduced the statistical power of our samples dramatically. It should
also be noted that the non-significance of FTO SNP may be partly
explained by the similar BMI between the cases and controls in
our samples, as FTO variant increases type 2 diabetes risk mainly
through increasing BMI. However, we failed to replicate the
effects of SNPs reported by DIAGRAM study. As these loci were
identified by a meta-analysis in over 10,000 individuals and
replicated in over 50,000 independent samples [6], the effect sizes
of these genes were relatively low compared with other loci.
Moreover, several SNPs (rs7578597spor and rs2641348) were rare
variants in the Asian populations. Therefore, we did not have
enough power to replicate these associations in our samples. But
the risk alleles of all the SNPs were the same as reported in the
Caucasians [6].
We also found rs7578597, a non-synonymous variant of
THADA, was associated with 2-h insulin levels in the controls.
Evidence showed THADA might be involved in the death receptor
pathway and apoptosis [22]. But whether THADA has similar
effect on beta cell and how it participates in the pathogenesis of
type 2 diabetes and insulin secretion is still unknown. Several study
suggested the predominant effect of the genetic contribution to
type 2 diabetes was mediated through defect in insulin secretion
rather than action [23,24]. But none of the SNPs we analyzed
showed association to HOMA-B. Wu et al [12] reported that
SNPs from CDKN2A-CDKN2B, IGF2BP2 and SLC30A8 showed
association to beta cell function in the Chinese; however, negative
finding was also reported in the current study and another study
with equivalent sample size [11]. Thus the effects of these variants
on clinical characteristics in the Chinese still need to be
investigated in cohorts with more samples.
The joint effect analysis showed that these susceptible loci
worked in an additive way and the subgroup of populations with
more risk alleles tended to have a higher risk for the disease.
However, the predictive value of these risk variants was limited in
our samples. This was similar to the previous findings in
Caucasians [25,26]. But we found the patients with more risk
alleles tended to have an earlier onset age of diabetes. Whether
individuals with extremely more risk alleles could benefit from
genetic testing and whether lifestyle intervention could reduce the
risk in this subgroup of individuals remained to be investigated.
Although the findings presented are interesting, they should be
viewed with caution. First, we cannot fully exclude the possibility
Table 3. Association of SNPs with clinical features related to glucose metabolism in the control subjects.
Traits Gene SNP AA Aa aa P Empirical P
Fasting glucose (mmol/l) SLC30A8 rs13266634 5.0260.02 4.9960.02 4.9360.03 0.0118 0.1698
2-h glucose (mmol/l) TSPAN8-LGR5 rs7961581 5.4260.04 5.4860.05 5.7560.14 0.0404 0.3546
Fasting insulin (pmol/l) TSPAN8-LGR5 rs7961581 45.3160.98 52.3161.79 47.8064.16 0.0054 0.0759
2-h insulin (pmol/l) CDKN2A-CDKN2B rs10811161 241.6968.74 257.9367.21 284.54614.22 0.0257 0.2927
2-h insulin (pmol/l) JAZF1 rs864754 268.9667.11 248.2368.35 225.81615.18 0.0110 0.1489
2-h insulin (pmol/l) TSPAN8-LGR5 rs7961581 247.8666.16 268.6868.80 323.46653.78 0.0171 0.2088
2-h insulin (pmol/l) THADA rs7578597 258.9065.05 165.79639.03 / 0.0005 0.0090
HOMA-IR TSPAN8-LGR5 rs7961581 1.6660.04 1.9360.07 1.7560.16 0.0039 0.0609
Only SNPs showed nominal significant association to clinical features are shown in the table. AA represents the homozygotes of major allele. Aa represents the
heterozygotes. aa represents the homozygotes of minor allele. Empirical P values were calculated through 1,000 permutations within each trait.
doi:10.1371/journal.pone.0007643.t003
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the cases and controls were recruited from the same city, recent
large-scale migration from other regions of the country into
Shanghai may lead to some degree of stratification. However,
according to the records of our standard questionnaires, all of our
samples lived in Eastern China more than three generations, thus
the effect of population stratification may be limited in our
samples. Second, as multiple traits were analyzed in the current
study, the possibility still exists that our findings were false positive,
especially for the continuous traits which lack replication in other
independent samples.
In conclusion, we confirmed the association between PPARG,
KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX,
IGF2BP2, SLC30A8 variants and type 2 diabetes. These risk loci
contributed to type 2 diabetes additively. Further studies in
Asian cohorts with prospective data and information on
environmental factors are needed to better elucidate the effects
of these genetic variants on diabetes risk and their interaction
with environment.
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Figure 1. The joint effect of risk alleles on type 2 diabetes susceptibility. A. Distribution of number of risk alleles in the type 2 diabetes
patients and normoglycaemic controls. Black bar=normoglycaemic, white bar=type 2 diabetes. The proportion of type 2 diabetes patients increased
in the subgroups with more risk alleles (Ptrend=1.34E-30). B. The risk for type 2 diabetes increased according to the increase of number of risk alleles,
(OR 1.265 per each additional risk allele, P=2.66E-29). C. The age-at-diagnosis decreased according to the increase of number of risk alleles carried
(20.6060.17 years per each additional risk allele, P=0.0006). D. ROC curves for models containing number of risk alleles (AUC=0.621), clinical
characteristics including age, sex and BMI (AUC=0.614) and both (AUC=0.668).
doi:10.1371/journal.pone.0007643.g001
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